Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
02/1999
02/18/1999WO1999008299A1 Nonaqueous electrolyte for electrical storage devices
02/18/1999WO1999007699A1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
02/18/1999WO1999007695A2 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
02/18/1999WO1999007685A1 Antibiotic for methicillin resistant bacteria
02/18/1999WO1999007674A2 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
02/18/1999WO1998040055A3 Anti-epileptogenic agents
02/18/1999DE19735410A1 New stable fumarate salt of pyrimidinol derivative dopamine D3 receptor ligand, having improved solubility and suitable for oral administration
02/18/1999CA2300373A1 Immunomodulator exhibiting antimicrobial and antimycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as pulmonary chronic and non-specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
02/18/1999CA2297889A1 Alpha 1a adrenergic receptor antagonist
02/18/1999CA2297055A1 Antibiotic for methicillin resistant bacteria
02/18/1999CA2293451A1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
02/17/1999EP0896961A1 Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
02/17/1999CN1208405A Retroviral protease inhibiting compounds
02/17/1999CN1208404A Nitrogenous heterocyclic compounds
02/17/1999CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof
02/16/1999US5872301 Bifunctional precursors for the preparation of liquid crystals
02/16/1999US5872255 Conjugated organic compounds and preparation process
02/16/1999US5872125 Polymorphs of lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it
02/16/1999US5872122 Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation
02/16/1999US5872117 Treating cerebrovascular dementia, senile dementia, alzheimer's dementia, sequelae of ischemic encephalopathy and cerebral apoplexy
02/16/1999US5871665 Multilayer electrodes and polymer dispersion liquid crystals
02/11/1999WO1999006378A1 Irreversible inhibitors of tyrosine kinases
02/11/1999DE19835866A1 Preparation of 5-per-fluoroalkyl-uracil derivatives used as intermediates for e.g. anti-viral drugs
02/10/1999EP0896043A1 Adhesive
02/10/1999EP0677045B1 Catalytic oxidation process of thiols
02/10/1999CN1207733A Novel piperazinylalkylthiophrimidine derivs., pharmaceutical compositions contg. same and process for preparation of such compounds
02/10/1999CN1207725A Pesticides
02/09/1999US5869677 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
02/09/1999US5869667 Reacting 2-halopyrimidine with carbon monoxide and alcohol in presence of palladium/phosphine complex catalyst and base
02/09/1999US5869666 4',6'-cyclopropane-fused carboxylic nucleoside analogs in which the oxygen in the ribose ring is substituted for carbon; antimetabolites; locking dna in solution to examine dna-protein, dna-rna and dna-dna interactions
02/09/1999US5869665 Reacting 2-hydrazine precursor with hydrogen; cyclization
02/09/1999US5869520 Reducing intraocular pressure
02/09/1999US5869495 Treatment and/or prophylaxis of hyperglycaemia
02/09/1999US5869484 Treating diseases derived by acetylcholine deficiency; alzheimer*s disease
02/09/1999US5869476 Angiotensin ii antagonists; treating cardiovascular disorders
02/09/1999US5868960 Mesomorphic compound, liquid crystal composition containing the compound, liquid crystal device using the composition, liquid crystal apparatus and display method
02/04/1999WO1999005143A1 Novel compounds
02/04/1999WO1999005125A1 Substituted n-aryl-n-thioxocarbonyl sulfonamides as herbicides
02/04/1999WO1999005123A1 Novel pyrimidin derivatives
02/04/1999WO1999005122A1 Pyrimidyl oxyphenylacetic acid derivatives
02/04/1999WO1999005121A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
02/04/1999WO1999005107A1 Vitronectin receptor antagonist
02/04/1999WO1999005097A1 Liquid crystal propene or propenyl nitrile derivatives
02/04/1999WO1999005096A2 Urokinase inhibitors
02/04/1999DE19831093A1 Acetylene derivatives used as components of liquid crystal media
02/04/1999DE19731784A1 Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide Substituted N-aryl-N-thioxocarbonyl-sulfonamides
02/04/1999CA2297910A1 Vitronectin receptor antagonist
02/04/1999CA2294300A1 Urokinase inhibitors
02/03/1999EP0894791A1 Pyrimidine compounds, process for producing the same, and agricultural or horticultural bactericides
02/03/1999EP0894084A1 Cinnamic acid derivatives and their use as integrin antagonists
02/03/1999CN1041924C Sulfuric acid, sulfate, dithio-amino formic acid and its salt oxidation process
02/03/1999CN1041922C Pyrimidine derivant and preparation process thereof and composition containing same
02/02/1999US5866702 Purine inhibitors of cyclin dependent kinase 2
02/02/1999US5866613 Diethyltris/trimethylene/tetramine and salts
02/02/1999US5866580 Treating an illness caused by p. carinii and t. gondii
02/02/1999US5866578 Substituted pyrimidines for control of diabetic complications
02/02/1999US5866577 Aromatic amidine derivatives and salts thereof
02/02/1999US5866572 Receptor tyrosine kinase inhibitory properties, treatment of proliferative diseases such as cancer.
01/1999
01/28/1999WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
01/28/1999WO1999003818A1 New chemical compound suitable for use as an explosive, intermediate and method for preparing the compound
01/28/1999WO1998038984A3 Formulations for hydrophobic pharmaceutical agents
01/28/1999DE19731322A1 Pyrimidyloxyphenylessigsäurederivate Pyrimidyloxyphenylacetic acid derivatives
01/28/1999DE19720165A1 Production of polymeric compounds with nucleo-base substituent(s)
01/27/1999EP0893423A1 Liquid crystal compounds having fluorinated linkages, liquid crystal compositions, and liquid crystal display devices
01/27/1999EP0892790A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
01/27/1999EP0892789A1 Irreversible inhibitors of tyrosine kinases
01/27/1999EP0892788A1 Novel carboxylic acid derivatives, their production and use
01/27/1999EP0892787A1 NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
01/27/1999EP0892786A1 New carboxylic acid derivatives, their production and use
01/27/1999EP0892780A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
01/27/1999EP0759040B1 Carbonyl containing compounds and their derivatives as multi-functional fuel and lube additives
01/27/1999EP0555388B1 Insecticidal, acaricidal and fungicidal aminopyrimidines
01/27/1999CN1206411A Thiol derivatives with metallopeptidase inhibitory activity
01/27/1999CN1206408A Process for preparing 4,6-dichloro-pyrimidine
01/27/1999CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives
01/27/1999CN1206001A Substituted diaminocarboxylic acids
01/26/1999US5863951 N-(ortho-substituted benzyloxy) imine derivatives and their use as fungicides, acaricides or insecticides
01/26/1999US5863926 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
01/26/1999US5863925 Use of sulbutiamine in the treatment of Parkinson's disease, schizophrenia, alcoholism, and dysthymia
01/26/1999US5863924 5ht2b antagonist
01/26/1999US5863920 Anticarcinogenic agents and bactericides
01/26/1999US5863919 Lock and key micelles and monomer building blocks therefor
01/26/1999US5863914 Administering to human n,n-dimethylbenzene or n,n-dimethylnaphthalene-cyclic urea derivative to treat a disease-state caused by inhibition of factor xa
01/21/1999WO1999002501A1 Novel compounds
01/21/1999DE19730326A1 New N-substituted sulphonamide or sulphamide compounds
01/20/1999EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives
01/20/1999EP0891336A1 Substituted 1-methyl-3-benzyluracils
01/20/1999EP0891325A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
01/20/1999EP0790986B1 Aniline derivatives
01/20/1999EP0719259B1 Substituted pyridines and pyrimidines, process for producing them and their use as pesticides and fungicides
01/20/1999CN1205694A Quinazoline derivatives
01/20/1999CN1205693A Quinoline and quinazoline compounds useful in therapy
01/20/1999CN1205166A Method improving residual control of mites and prolonging protection of plants from mite infestations
01/20/1999CN1041727C Risperidone pamoate salt, its prepn. method and medicinal compsns. containing same
01/20/1999CN1041724C 2-arylaminopyrimidinone derivative, and herbicide and plant growth regulator using same
01/19/1999US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases
01/19/1999US5861421 Useful for treating allergic and inflammatory diseases
01/19/1999US5861401 Treatment of congestive heart failure
01/19/1999US5861398 Benzoperimidine-carboxylic acids and derivatives thereof
01/19/1999US5861109 Liquid crystal materials, mixtures and devices